LONDON--(BUSINESS WIRE)--Jul 10, 2018-- analysts forecast the global artificial organs market is expected to grow at a CAGR of around 10% during the period 2018-2022, according to their latest market research report.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180710005762/en/

Technavio has published a new market research report on the global artificial organs market from 2018-2022. (Graphic: Business Wire)

The emergence of total artificial hearts (TAH) is one of the major trends being witnessed in the . TAH has emerged as an effective treatment option for patients with end-stage biventricular heart failure, awaiting orthotopic heart transplantation. Their use as an intermediate to heart transplantation was recently approved globally.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global artificial organs market is the increasing prevalence of chronic disorders:

Global artificial organs market: Increasing prevalence of chronic disorders

The increase in the prevalence of cardiovascular diseases (CVDs) such as strokes and cardiac diseases, diabetes, chronic kidney diseases, hearing disorders and rise in aging population are likely to increase the demand for artificial organs. The rise in physical inactivity and unhealthy diets has led to an increase in chronic diseases and cardiovascular disorders leading to an increase in demand for devices such as pacemakers and total artificial hearts.

According to a senior market research analyst at Technavio, “The global artificial organs market is highly competitive, and vendors are offering differentiated novel products to sustain in the market and gain revenues. Several manufacturers are focusing on developing artificial organs with improved patient comfort. Manufacturers are also making significant investments in R&D to cater to the requirements of end-users. This is expected to result in new developments and clinical applications of artificial organs.”

Global artificial organs market: Segmentation analysis

The global artificial organs market research report provides market segmentation by product (artificial heart, artificial kidney, cochlear implants, and artificial pancreas), by end-user (hospitals and clinics, ASCs, dialysis centers, and others), and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The hospitals and clinics segment was the largest end-user segment in 2017 with a market share of 45%. Hospitals provide all the treatment services for chronic diseases with minimally invasive surgeries. Large hospitals have more than 500 hospital beds and they provide many inpatient and outpatient medical facilities.

The Americas held the largest share of the market in 2017, accounting for close to 47% share, followed by the EMEA and APAC respectively. Although APAC held the smallest share of the market, it is expected to witness the maximum increase in its market share over the forecast period owing to the presence of a large patient pool and improvements in hospital infrastructure. Japan, China, and Australia are the major revenue contributors in the region.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market sizing Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20180710005762/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: SURGERY HEALTH CARDIOLOGY HOSPITALS MEDICAL DEVICES

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 07/10/2018 11:33 AM/DISC: 07/10/2018 11:33 AM

http://www.businesswire.com/news/home/20180710005762/en